As the HIV research community prepares to convene for the Conference on Retroviruses and Opportunistic Infections (CROI) 2026 ...

From clinic closures to gene therapy costs, new data reveal how policy, prices, and structural racism reshape US health ...

In the final episode, Assessing Long-Term Renal Outcomes and Kidney Failure Risk Reduction in IgA Nephropathy, the panelists ...

This episode, titled Positioning Emerging Targeted Therapies in the Evolving IgA Nephropathy Treatment Paradigm, features ...

Chomont is a Professor in the Department of Microbiology, Infectious Diseases, and Immunology at the Université de Montréal and a researcher at the CHUM Research Centre CROI 2026 highlights will ...

Julie Rosenthal, MD, MS, discusses signs and symptoms of age-related macular degeneration as well as methods of treatment.

Compensation reforms prohibit price- or rebate-linked PBM revenue in Part D, pushing flat service-fee models and broadly capturing affiliates such as rebate GPOs and aggregators. Reform priorities aim ...

Medicare Part B IV/RPT administrations rose from 529 (2013) to 12,395 (2023), with diagnostic/interventional radiology leading volume, followed by nuclear medicine, radiation oncology, and medical ...

FDA cleared acalabrutinib plus venetoclax as the only all-oral, fixed-dose combination option for first-line, treatment-naïve CLL/SLL. Phase 3 AMPLIFY showed superior PFS versus chemoimmunotherapy, ...

Federal levers include authorization, guideline-linked insurance coverage, and Vaccines for Children funding, whereas states can set school-entry mandates and choose alternative guidance frameworks.

A US-focused cohort study published in 2023 showed similar trends, with a higher AA incidence observed among women (range, ...

Treatment approaches have shifted with the introduction of targeted agents, notably Bruton tyrosine kinase (BTK) inhibitors, ...